With one minor procedural observationJ B Chemicals & Pharmaceuticals announced that the company's US FDA approved solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat has successfully passed periodical inspection by US FDA with one minor procedural observation. This observation do not impact continuity of Company's business and the Company would continue its manufacturing activities in cGMP compliant manner. The Company proposes to address this observation in the next 15 days. The said inspection was carried-out from 3 February 2020 to 7 February 2020.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)